1. TEConomy Partners. The Economic Impact of the US Biopharmaceutical Industry: National and State Estimates
http://phrma-docs.phrma.org/sites/default/files/pdf/biopharmaceuticaul-industry-economic-impact.pdf
(Washington, DC: Pharmaceutical Research and Manufacturers of America, 2016).
2. Cortright, J. & Mayer, H. Signs of Life: the Growth of Biotechnology Centers in the US
https://www.brookings.edu/wp-content/uploads/2016/06/biotech.pdf
(Center on Urban and Metropolitan Policy, The Brookings Institution, 2002).
3. Golec, J. & Vernon, J.A. Financial risk of the biotech industry versus the pharmaceutical industry. Appl. Health Econ. Health Policy 7, 155–165 (2009).
4. Cockburn, I. & Lerner, J. The cost of capital for early stage biotechnology ventures. Congressional Briefing
http://buchpedersen.com/wp-content/uploads/2016/02/The-Cost-of-Capital-for-Early-Stage-Biotechnology-Ventures_CockburnLerner.pdf
(2009).
5. Finkelstein, S. & Temin, P. Reasonable Rx: Solving the Drug Price Crisis. (FT Press, 2008).